Analysis of Vital Signs in Patients With COVID-19

NCT04927078 | Completed

• 1 other identifier: 287454
• Study Type: observational
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

This project will use data obtained from a proprietary vision-based patient monitoring and management system (OxeVision) for measuring heart rate and respiratory rate which is in clinical use at the Coventry and Warwickshire Partnership NHS Trust.

Conditions

Respiratory Disease

Keywords

Breathing rate; Pulse rate; COVID 19; Patient monitoring

Outcome Measures

Primary Outcomes (1)

• Breathing rates

  Breathing rates collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.

  Data will be collected throughout study completion, an average of 7 months, to obtain breathing rate before and after the diagnosis of COVID 19.

Secondary Outcomes (2)

• Pulse rates

  Data will be collected throughout study completion, an average of 7 months, to obtain pulse rate before and after the diagnosis of COVID 19.

• BR and PR

  Data will be collected throughout study completion, an average of 7 months, to obtain breathing and pulse rate before and after the diagnosis of COVID 19.

Study Arms (2)

Participants with COVID 19 diagnosis

We will measure the breathing rate (BR) before and after the clinical diagnosis of COVID 19.

Other: Observation of breathing pattern

Participants without COVID 19 diagnosis

Breathing rates will be measured for the same time duration as the cases.

Other: Observation of breathing pattern

Interventions

Observation of breathing pattern OTHER

Observations will be collected using a remote vision based patient monitoring and management system.

Participants with COVID 19 diagnosis; Participants without COVID 19 diagnosis

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult participants admitted to inpatient mental health wards.

You may qualify if:

• Patients age 18 and above. Patients on wards with a medical diagnosis of COVID 19 who are in rooms with the Vision based patient monitoring and management system.

You may not qualify if:

• Children will be excluded. No data will be excluded unless specifically requested by the treating clinician.

Sponsors & Collaborators

• Oxehealth Limited: lead
• Royal Brompton & Harefield NHS Foundation Trust: collaborator

Study Sites (1)

Coventry and Warwickshire Partnership NHS

Coventry, United Kingdom

Location

MeSH Terms

Conditions

Respiration Disorders; COVID-19

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases

Study Officials

• Michael Polkey

  The Royal Bromptom Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 13, 2021
• First Posted: June 15, 2021
• Study Start: April 1, 2020
• Primary Completion: October 31, 2020
• Study Completion: October 31, 2020
• Last Updated: June 15, 2021

Record last verified: 2021-06

Locations

GB (1)